• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Dominari Holdings Inc.

    4/29/25 12:15:09 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DOMH alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: April 28, 2025 5:00 P.M.
    Form: S-3
    CIK: 0000012239
    Company Name: Dominari Holdings Inc.
    File Number: 333-286648
    Get the next $DOMH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOMH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DOMH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ledwick Tim S bought 8,645 shares and was granted 10,000 shares, increasing direct ownership by 145% to 31,471 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 5:03:10 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Lieberman Ronald J. bought 21,613 shares and was granted 10,000 shares (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 5:00:46 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President Wool Kyle Michael bought 288,184 shares, increasing direct ownership by 15% to 2,200,769 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    2/12/25 4:58:43 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dominari Holdings Applauds American Bitcoin's Nasdaq Debut; Highlights Strategic Stake

    Dominari Holdings Inc. Holds Approximately 23,199,205 Shares of American Bitcoin (NASDAQ:ABTC), Valued at Approximately $170 Million at ABTC's September 5, 2025 Close NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) ("Dominari" or the "Company") (NASDAQ:DOMH) today congratulated American Bitcoin ("ABTC") on its successful listing on the Nasdaq Stock Market. Dominari holds approximately 23,199,205 shares of ABTC. Based on ABTC's closing price of $7.40 per share on September 5, 2025, Dominari's position had an approximate market value of $171,674,117 at the time of that close.

    9/9/25 8:00:00 AM ET
    $ABTC
    $DOMH
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Files $2 Billion Shelf to Support Strategic Expansion

    NEW YORK, Aug. 28, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced the filing of its shelf registration statement (the "Shelf Registration") on Form S-3 with the U.S. Securities and Exchange Commission (the "SEC"). If the Shelf Registration is declared effective, it will permit the Company to offer and sell, from time to time in one or more offerings, up to $2 Billion worth of shares of common stock, preferred stock, or any combination thereof (the "securities"). Although we have no current intention to use the Shelf Registration Statement, depending on numerous factors, including the development of current and future business initiatives, we intend to use the net p

    8/28/25 8:15:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Forms Crypto Advisory Board to Support Strategic Expansion

    Positioning to be a Bridge Between Traditional Finance and the Next Generation of Blockchain Innovation NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced the formation of a new Crypto Advisory Board to support its expansion into crypto currency. This initiative underscores Dominari's commitment to expanding its presence in the rapidly evolving digital asset sector. Crypto Advisory Board Members The newly established Crypto Advisory Board will provide strategic guidance as Dominari pursues acquisitions and partnerships in the digital a

    8/26/25 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    SEC Filings

    View All

    SEC Form S-3 filed by Dominari Holdings Inc.

    S-3 - Dominari Holdings Inc. (0000012239) (Filer)

    8/28/25 8:01:40 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Dominari Holdings Inc.

    10-Q - Dominari Holdings Inc. (0000012239) (Filer)

    8/11/25 5:31:23 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Dominari Holdings Inc. (0000012239) (Filer)

    6/27/25 4:15:26 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Hayes Anthony gifted 15,000 shares, decreasing direct ownership by 0.92% to 1,614,566 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    5/6/25 4:15:04 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by President Wool Kyle Michael

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    4/16/25 7:55:12 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by CEO Hayes Anthony

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    4/16/25 7:54:31 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Leadership Updates

    Live Leadership Updates

    View All

    Dominari Holdings Set to Join Russell Microcap® Index

    NEW YORK, May 28, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), is set to join the Russell Microcap® Index at the conclusion of the 2025 Russell indexes annual reconstitution, effective after the US market opens on June 30, according to a preliminary list of additions posted May 23. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Wednesday, April 30, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth

    5/28/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team

    Edward Deignan Appointed as VP of Finance and Accounting Kyle Degruttola Appointed as Controller NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that it has appointed Edward Deignan as Vice President of Finance and Accounting and Kyle Degruttola as Controller. Together, they bring decades of accounting and finance leadership experience from various multi-national and public sector organizations.Mr. Deignan is responsible for the day-to-day management of the Company's financial operations. He brings with him more than 30 years of experience in accounting, finance and banking. He has served as a chief financial officer for s

    11/11/24 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Securities LLC Announces Appointment of Capital Markets Veteran James Hopkins as Managing Director Head of Capital Markets

    Hopkins has Led and Structured Hundreds of Capital Markets Transactions NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today noted that its wholly-owned subsidiary, Dominari Securities LLC ("Dominari"), announced that it has further expanded its practice with the appointment of capital markets veteran James (Jimmy) Hopkins as Managing Director Head of Capital Markets.Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "Our commitment to positioning Dominari as a full-service, diversified financial services firm and growing our business remains stronger than ever, and Jimmy has a proven record of success with hundreds of completed tran

    10/7/24 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Financials

    Live finance-specific insights

    View All

    Dominari Holdings Announces Record Date for Cash Dividend

    NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) is pleased to announce that its board of directors has authorized a special cash dividend of, in the aggregate, approximately $5 million, or $0.22 per share. The dividend is expected to be payable on or around September 26, 2025, to DOMH's shareholders and certain DOMH warrant holders (on an as-exercised basis) of record as of the close of business on September 3, 2025. For additional information about Dominari Holdings Inc., please visit: https://www.dominariholdings.com/ About Dominari Holdings Inc.

    8/22/25 9:15:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Marks Inflection Point with Second Quarter 2025 Financial Results

    Revenue of $34.1 Million, up 520%Closed 46 Transactions in Q2 with Total Raise Amount of More Than $288.9 Million between both our Private & Public TransactionsNEW YORK, Aug. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced financial results for the quarter that ended June 30, 2025. The results underscore a significant inflection point for the Company, which delivered breakout performance during the quarter. "This quarter marks a turning point for Dominari," said Anthony Hayes, Chief Executive Officer of Dominari Holdings. "Revenue reached $34.1 m

    8/12/25 9:15:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

    Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

    3/31/25 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

    6/13/24 8:56:04 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

    6/13/24 4:32:07 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care